Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for Hepion Pharmaceuticals, Inc., €22k.
Filing timeline
BuySaleGary S. Stetz II
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +12.9%Entry US$0.07 · Close at T+30 US$0.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary S. Stetz II: trading record in brief
Gary S. Stetz II has a single filing on record, published on 12 August 2026: an open-market purchase of €22k in Hepion Pharmaceuticals, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary S. Stetz II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 500,000 shares@ US$0.050.43% mcap100.0% of flowCommon StockSEC:0001493152-26-037500:0Canonical exit: 1 Nov 2026 (T+90)
1 of 1 declaration